Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Cardiovascular diseases (CVDs) constitute the prime cause of global mortality, with an
immense impact on patient quality of life and disability. Clinical evidence has revealed a …
immense impact on patient quality of life and disability. Clinical evidence has revealed a …
Role of inflammation in atrial fibrillation pathophysiology and management
Atrial fibrillation (AF) is the most common clinically relevant arrhythmia, but the methods
available for treating AF and its complications (of which the most important is …
available for treating AF and its complications (of which the most important is …
[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …
JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias
K Ono, Y Iwasaki, M Akao, T Ikeda, K Ishii… - Circulation …, 2022 - jstage.jst.go.jp
The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …
[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
F Casselman, A Coca, R De Caterina… - European heart …, 2016 - academia.edu
Surveys and registries are needed to verify that real-life daily practice is in kee** with what
is recommended in the guidelines, thus completing the loop between clinical research …
is recommended in the guidelines, thus completing the loop between clinical research …
Atrial fibrillation and the risk of myocardial infarction
Importance Myocardial infarction (MI) is an established risk factor for atrial fibrillation (AF).
However, the extent to which AF is a risk factor for MI has not been investigated. Objective …
However, the extent to which AF is a risk factor for MI has not been investigated. Objective …
Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices
DT Martin, MM Bersohn, AL Waldo… - European heart …, 2015 - academic.oup.com
Abstract Aims Atrial tachyarrhythmias (ATs) detected by implanted devices are often atrial
fibrillation or flutter (AF) associated with stroke. We hypothesized that introduction and …
fibrillation or flutter (AF) associated with stroke. We hypothesized that introduction and …
Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation
Background: Transcutaneous low-level tragus electrical stimulation (LLTS) suppresses atrial
fibrillation (AF) in canines. Objectives: This study examined the antiarrhythmic and anti …
fibrillation (AF) in canines. Objectives: This study examined the antiarrhythmic and anti …
Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate
JJ Goldberger, R Arora, D Green, P Greenland… - Circulation, 2015 - Am Heart Assoc
Atrial disease or myopathy forms the substrate for atrial fibrillation (AF) and underlies the
potential for atrial thrombus formation and subsequent stroke. Current diagnostic …
potential for atrial thrombus formation and subsequent stroke. Current diagnostic …
Role of inflammation in the pathogenesis of atrial fibrillation
K Ihara, T Sasano - Frontiers in Physiology, 2022 - frontiersin.org
Atrial fibrillation (AF) is one of the most common arrhythmias encountered in clinical practice.
AF is a major risk factor for stroke, which is associated with high mortality and great disability …
AF is a major risk factor for stroke, which is associated with high mortality and great disability …